Furthermore, serum TGF-β1 concentrations appear to be an efficient prognostic biomarker associated with time to recovery, need for advanced respiratory support, ICU admission and the development of nosocomial infections in COVID-19 patients. The gene discussed is TGFB1; the disease is COVID-19.